Synthesis of enhanced fluorescent graphene quantum dots for catecholamine neurotransmitter sensing

Recent Advances in Catecholamines Analytical Detection Methods and Their Pretreatment Technologies

Catecholamines (CAs), including adrenaline, noradrenaline, and dopamine, are neurotransmitters and hormones that play a critical role in regulating the cardiovascular system, metabolism, and stress response in the human body. As promising methods for real-time monitoring of catecholamine neurotransmitters, LC-MS detectors have gained widespread acceptance and shown significant progress over the past few years. Other detection methods such as fluorescence detection, colorimetric assays, surface-enhanced Raman spectroscopy, and surface plasmon resonance spectroscopy have also been developed to varying degrees. In addition, efficient pretreatment technology for CAs is flourishing due to the increasing development of many highly selective and recoverable materials. There are a few articles that provide an overview of electrochemical detection and efficient enrichment, but a comprehensive summary focusing on analytical detection technology is lacking. Thus, this review provides a comprehensive summary of recent analytical detection technology research on CAs published between 2017 and 2022. The advantages and limitations of relevant methods including efficient pretreatment technologies for biological matrices and analytical methods used in combination with pretreatment technology have been discussed. Overall, this review article provides a better understanding of the importance of accurate CAs measurement and offers perspectives on the development of novel methods for disease diagnosis and research in this field.

A novel RhB@MOF-808 fluorescent probe for the rapid detection of dopamine and Fe3

Dopamine (DA) and Fe³⁺ as the important bioactive ingredients, playing an indispensable role in human metabolism. Therefore, developing the accurate detection of DA and Fe³⁺ is of great significance for disease screening. Herein, we put forward a simple, rapid, and sensitive fluorescent detection strategy for the detection of dopamine and Fe³⁺ based on Rhodamine B-modified MOF-808 (RhB@MOF-808). RhB@MOF-808 produced strong fluorescence at 580 nm, and the fluorescence was significantly quenched after DA or Fe³⁺ was added, which was regarded as a static quenching process. Detection limits are as low as 60.25 nM and 48.34 nM, respectively. Furthermore, based on the responses of DA and Fe³⁺ to the probe, molecular logic gates were successfully designed. More importantly, RhB@MOF-808 had excellent cell membrane permeability and had been successfully used to label DA and Fe³⁺ in Hela cells, which presented a potential biological application value as a fluorescent probe for detecting DA and Fe³⁺.

Phthalylglycyl Chloride as a Derivatization Agent for UHPLC-MS/MS Determination of Adrenaline, Dopamine and Octopamine in Urine

Dopamine, adrenaline and octopamine are small polar molecules that play a vital role in regulatory systems. In this paper, phthalylglycyl chloride was proposed as a derivatization agent for octopamine, adrenaline and dopamine determination in urine for the first time. The derivatization procedure facilitated the use of reversed-phase liquid chromatography with positive electrospray ionization-high-resolution mass spectrometry. An LC-HRMS method was developed that provided quantification limits of 5 ng/mL and detection limits of 1.5 ng/mL for all analytes. The 95-97% yield of derivates was observed after a 10 min derivatization with phthalylglycyl chloride at pH 6.5 and 30 °C. The proposed method was successfully applied to the analysis of human urine samples. The obtained results were compared with those of conventional derivatization procedures with 9-fluorenyl-methoxycarbonyl chloride and dansyl chloride.

Microplasma-Tunable Graphene Quantum Dots for Ultrasensitive and Selective Detection of Cancer and Neurotransmitter Biomarkers

The effective and precise detection of cancer and neurotransmitter biomarkers including folic acid (FA), dopamine (DA), and epinephrine (EP) are essential for early detection and diagnosis of cancer and neurological disorders and for the development of new drugs. However, it remains challenging to detect FA, DA, and EP with high selectivity and sensitivity with a single material. Herein, we report a photoluminescence (PL)-based selective sensing of FA, DA, and EP with nitrogen-doped graphene quantum dots (NGQDs) synthesized from biocompatible chitosan under ambient conditions using atmospheric pressure microplasmas. By regulating the pH, the selective detection is achieved in broad ranges from 0.8 to 80 μM for FA and 0.4 to 100 μM for both DA and EP with the very low limits of detections of 81.7, 57.8, and 16.7 nM for FA, DA, and EP, respectively. The developed PL sensing method shows the high throughput of 5000 detections per hour. Moreover, highly stable colloidal NGQD dispersion with 100 μg/mL concentration for at least 100 PL detections is produced in 1 h by a single microplasma, and the process is scalable. The mechanisms of the outstanding performance are related to the enhanced, size-dependent π-π stacking attraction between the NGQDs and the pH-regulated chemical states of the analytes and the associated pH-specific photo-induced electron transfer and PL.